Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
NCT00092001
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
111
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG:
Sunitinib
Sponsor
Pfizer